Publications by authors named "C Mulot"

Claim this Profile
N
Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.
M Ambrosini, H Blons, S Garinet, C Mulot, D Le Corre

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a very-high risk subgroup of localized endometrial carcinoma before surgery using circulating tumor DNA: a proof-of-concept study.
Antoine Gaudet Chardonnet, Bruno Borghese, Jérôme Alexandre, Camille Richard, Marie Métairie, Claire Mulot

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial.
Julien Taïeb, Francesco Giulio Sullo, Aurélie Lecanu, Camille Bourreau, Emilie Barbier, Claire Mulot

JAMA Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.
H Blons, J Abdelli, S Landman, V Taly, C Mulot

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in circadian rhythm genes and the risk of differentiated thyroid cancer.
Takiy-Eddine Berrandou, Emilie Cordina-Duverger, Claire Mulot, Anne-Valérie Guizard, Claire Schvartz

Front Genet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis